...
首页> 外文期刊>Journal of neuro-oncology. >MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression
【24h】

MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression

机译:MicroRNA-9通过抑制Stathmin表达抑制神经胶质瘤细胞系的血管生成模拟

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to investigate the functions of microRNA-9, which is a tissue-specific microRNA in central nervous system, in the vasculogenic mimicry (VM) of glioma cell lines in vitro and in vivo.Glioma cell lines U87MG, U251 and SHG44 were transfected with microRNA-9 mimic, microRNA-9 inhibitor or scramble sequences. The amount of microRNA-9 and Stathmin (STMN1) mRNA was determined by quantitative real-time PCR, and the protein expression of STMN1 was determined by western blot. Cell proliferation and apoptosis were assessed. The interactions between the 3′UTR of STMN1 and miR-9 was determined by luciferase reporter assay. The VM capacity in vitro was evaluated using VM formation assay, and the rescue experiment of STMN1 was carried out in U251 cells. The in vivo experiment was applied with animal models implanted with U87MG cells.MicroRNA-9 mimic transfection reduced proliferation and increased apoptosis in glioma cell lines (p < 0.05). MicroRNA-9 mimic up-regulated STMN1 mRNA levels but reduced its protein levels (p < 0.05), and luciferase activity of STMN1 was suppressed by microRNA-9 mimic transfection (p < 0.05). Furthermore, microRNA-9 mimic transfection suppressed tumor volume growth, as well as VM both in vitro and in vivo. The cell viability and microtube density were upregulated in U251 cells after STMN1 up-regulation (p < 0.05). STMN1 is a target of microRNA-9, and microRNA-9 could modulate cell proliferation, VM and tumor volume growth through controlling STMN1 expression. MicroRNA-9 and its targets may represent a novel panel of molecules for the development of glioma treatment.
机译:这项研究的目的是研究神经胶质瘤细胞系U87MG,U251在神经胶质瘤细胞系的血管生成模拟(VM)中的功能-microRNA-9是中枢神经系统中的组织特异性microRNA的功能。用microRNA-9模拟物,microRNA-9抑制剂或加扰序列转染SHG44和SHG44。通过定量实时PCR测定microRNA-9和Stathmin(STMN1)mRNA的量,并通过western blot测定STMN1的蛋白表达。评估细胞增殖和凋亡。通过荧光素酶报告基因测定,确定STMN1的3'UTR与miR-9之间的相互作用。使用VM形成测定法评估体外VM容量,并在U251细胞中进行STMN1的拯救实验。体内实验应用于植入了U87MG细胞的动物模型。MicroRNA-9模拟转染减少了神经胶质瘤细胞系的增殖并增加了细胞凋亡(p <0.05)。 MicroRNA-9模拟上调STMN1 mRNA水平,但降低其蛋白质水平(p <0.05),并且microRNA-9模拟转染抑制了STMN1的荧光素酶活性(p <0.05)。此外,microRNA-9模拟转染在体外和体内均抑制了肿瘤体积的生长以及VM。 STMN1上调后,U251细胞的细胞活力和微管密度上调(p <0.05)。 STMN1是microRNA-9的靶标,而microRNA-9可以通过控制STMN1的表达来调节细胞增殖,VM和肿瘤体积的生长。 MicroRNA-9及其靶标可能代表了用于胶质瘤治疗发展的新型分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号